Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
PTC Therapeutics, Inc. - Common Stock
(NQ:
PTCT
)
73.69
+9.20 (+14.27%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 8, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about PTC Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Palo Alto Networks To Rally Around 21%? Here Are 10 Other Analyst Forecasts For Thursday
↗
May 18, 2023
Needham raised the price target for Dynatrace, Inc. (NYSE: DT) from $52 to $56. Needham analyst James Ricchiuti maintained a Buy rating. Dynatrace shares gained 1.9% to $47.95 in pre-market trading.
Via
Benzinga
Why PTC Therapeutics Could Be Victorious In Its Rare-Disease Battle Against BioMarin Pharmaceuticals
↗
May 17, 2023
The company is working on a treatment for PKU, a disorder that can lead to intellectual disabilities.
Via
Investor's Business Daily
The Latest Analyst Ratings for PTC Therapeutics
↗
May 08, 2023
Via
Benzinga
PTC Therapeutics's Return On Capital Employed Insights
↗
May 04, 2023
Via
Benzinga
Why did Sarepta Therapeutics Stock Plummet?
March 21, 2023
SRPT stock fell 20% after the FDA changed course on their new DMD treatment approval. The stock remains strong with an encouraging outlook and a mod Buy rating.
Via
MarketBeat
Where PTC Therapeutics Stands With Analysts
↗
March 17, 2023
Via
Benzinga
Looking Into PTC Therapeutics's Return On Capital Employed
↗
February 22, 2023
Via
Benzinga
Earnings Outlook For PTC Therapeutics
↗
February 20, 2023
Via
Benzinga
Expert Ratings for PTC Therapeutics
↗
December 14, 2022
Via
Benzinga
Earnings Scheduled For April 27, 2023
↗
April 27, 2023
Companies Reporting Before The Bell • Cazoo Gr (NYSE:CZOO) is expected to report earnings for its first quarter.
Via
Benzinga
Analyst Expectations for PTC Therapeutics's Future
↗
April 18, 2023
Via
Benzinga
PTC Therapeutics Gets $1B Funding From Blackstone, Shares Fall
↗
October 28, 2022
Via
Benzinga
Reaction Is Overdone For PTC Therapeutics Pausing Huntington Trial Enrollment, Analyst Says
↗
October 19, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023
↗
March 17, 2023
Via
Benzinga
7 Nasdaq Stocks to Sell Before They Plunge in 2023
↗
December 05, 2022
While loyalty may be a positive trait in most circumstances, when it comes to Nasdaq stocks to sell, you got to look out for number one.
Via
InvestorPlace
PTC Therapeutics's Return On Capital Employed Overview
↗
November 02, 2022
According to Benzinga Pro data, during Q3, PTC Therapeutics (NASDAQ:PTCT) posted sales of $217.13 million. Earnings were up 28.12%, but PTC Therapeutics still reported an overall loss of $109.31...
Via
Benzinga
PTC Therapeutics Pauses Enrollment In Huntington's Candidate Trial In US
↗
October 19, 2022
Via
Benzinga
What 5 Analyst Ratings Have To Say About PTC Therapeutics
↗
October 17, 2022
Within the last quarter, PTC Therapeutics (NASDAQ:PTCT) has observed the following analyst ratings:
Via
Benzinga
Expert Ratings for PTC Therapeutics
↗
October 17, 2022
Analysts have provided the following ratings for PTC Therapeutics (NASDAQ:PTCT) within the last quarter:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
↗
December 14, 2022
Via
Benzinga
Analyst Ratings for PTC Therapeutics
↗
October 17, 2022
Within the last quarter, PTC Therapeutics (NASDAQ:PTCT) has observed the following analyst ratings:
Via
Benzinga
Why Pinterest Shares Jumped Around 14%; Here Are 69 Biggest Movers From Friday
↗
October 31, 2022
Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) jumped 153.9% to close at $3.30 on Friday.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
October 28, 2022
Gainers Nuvalent (NASDAQ:NUVL) stock increased by 15.9% to $25.5 during Friday's pre-market session. The company's market cap stands at $1.2 billion.
Via
Benzinga
Why Edwards Lifesciences Shares Are Trading Lower By Around 17%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
↗
October 28, 2022
Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) surged 179% to $3.6301.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
October 19, 2022
Gainers Kintara Therapeutics (NASDAQ:KTRA) shares moved upwards by 74.8% to $0.17 during Wednesday's pre-market session. The company's market cap stands at $14.1 million.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
October 18, 2022
Gainers
Via
Benzinga
Earnings Scheduled For October 27, 2022
↗
October 27, 2022
Companies Reporting Before The Bell • Janus Henderson Gr (NYSE:JHG) is expected to report quarterly earnings at $0.48 per share on revenue of $494.27 million.
Via
Benzinga
Marten Transport, Silvergate Capital And Some Other Big Stocks Moving Lower On Tuesday
↗
October 18, 2022
U.S. stocks traded higher, with the Dow Jones gaining more than 250 points on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Roche's Muscular Atrophy Treatment Improves Motor Function In Pretreated Patients
↗
October 12, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2022
↗
September 12, 2022
Upgrades
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
